Biochemical characterization and biological effects of partially purified b cell-activating factor (bcaf)
✍ Scribed by Claude Roth; Jean-Louis Moreau; Marie Korner; Dragana Jankovic; Jacques Thèze
- Publisher
- John Wiley and Sons
- Year
- 1988
- Tongue
- English
- Weight
- 811 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
✦ Synopsis
B cell-activating factor (BCAF) has been characterized and partially purified from the supernatant of the murine tumor T cell line 373. BCAF has an apparent molecular mass of 15 to 20 kDa when analyzed by Superose 12 fast protein liquid chromatography (FPLC) gel filtration and a pI of 4.5 to 5.0 when analyzed by FPLC chromatofocusing. Concentrated supernatant was applied to a nickel chelating column and unadsorbed active material was further purified by two sequential C4 reverse-phase high-performance liquid chromatography steps. This purification procedure allowed a complete separation of interleukin 2 and interleukin 4 activities from BCAF. This partially purified BCAF induces Ia expression, cell size increase and proliferation of small resting B cells. Furthermore, we have shown that the activity of partially purified BCAF is insensitive to treatment by monoclonal antibodies specific for interleukin 4 and interleukin 5.
📜 SIMILAR VOLUMES
A specific acetylhydrolase that inactivates platelet activating factor (PAF; 1alkyl-2-acetyl-sn-glycero-3-phosphocholine), a potent cellular mediator in mammalian cells, by removal of the sn-2 acetyl moiety, has been found in the cytosolic fraction of several postemhryonir developmental stages and s